Aurinia Pharmaceuticals, Inc. (AUPH)
15.15
-0.18
(-1.17%)
USD |
NASDAQ |
Jan 09, 16:00
15.17
+0.02
(+0.13%)
After-Hours: 20:00
Aurinia Pharmaceuticals Price: 15.15 for Jan. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Oncolytics Biotech, Inc. | 0.9677 |
| Edesa Biotech, Inc. | 1.50 |
| Lexaria Bioscience Corp. | 0.746 |
| Xenon Pharmaceuticals, Inc. | 42.15 |
| ProMIS Neurosciences, Inc. | 8.13 |
Price Related Metrics
| PE Ratio | 27.00 |
| PS Ratio | 8.042 |
| Price to Book Value | 5.461 |
| Price to Free Cash Flow | 17.76 |
| Earnings Yield | 3.70% |
| Market Cap | 1.997B |
| Operating PE Ratio | 22.01 |
| Normalized PE Ratio | 23.60 |